Evidence map›Paper›PMID 40785976›Full record

ArticleJornal vascular brasileiro2025

Prevalence of venous thromboembolism and associated factors in COVID-19 patients at a provincial public hospital in southern Brazil.

Bruna Valduga Dutra, Luana Valduga Dutra, Henrique Luiz Weber, Matheus Omairi Reinheimer, Matheos Pezzi, Gabriela Teixeira Macalossi, Simone Bonatto, Clandio de Freitas Dutra

Abstract read
In one paragraph

Article in Jornal vascular brasileiro, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Bruna Valduga DutraUniversidade de Caxias do Sul - UCS, Caxias do Sul, RS, Brasil.ORCID 0000-0002-8302-6737
Luana Valduga DutraUniversidade de Caxias do Sul - UCS, Caxias do Sul, RS, Brasil.ORCID 0000-0002-8397-9247
Henrique Luiz WeberUniversidade de Caxias do Sul - UCS, Caxias do Sul, RS, Brasil.ORCID 0009-0008-8099-0177
Matheus Omairi ReinheimerUniversidade de Caxias do Sul - UCS, Caxias do Sul, RS, Brasil.ORCID 0009-0000-7437-7423
Matheos PezziUniversidade de Caxias do Sul - UCS, Caxias do Sul, RS, Brasil.ORCID 0009-0001-5237-7382
Gabriela Teixeira MacalossiUniversidade de Caxias do Sul - UCS, Caxias do Sul, RS, Brasil.ORCID 0009-0004-4302-8174
Simone BonattoUniversidade de Caxias do Sul - UCS, Caxias do Sul, RS, Brasil.ORCID 0000-0001-7619-5930
Clandio de Freitas DutraUniversidade de Caxias do Sul - UCS, Caxias do Sul, RS, Brasil.ORCID 0000-0002-6097-7249

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: COVID-19 is a predominantly respiratory disease, but it also has a strong association with thromboembolism, especially among hospitalized patients. Objectives: To evaluate the prevalence of venous thromboembolism (VTE) and associated factors in patients with COVID-19 in a public hospital in the interior of South Brazil. Methods: A retrospective, cross-sectional observational study was carried out by analyzing data from medical records. The VTE outcome was a composite of acute pulmonary thromboembolism (PTE) and deep vein thrombosis (DVT). Associations were analyzed by logistic regression and bivariate analyses using Pearson's chi-square test. Results: The sample comprised 964 patients. 56% were male and 44% female, with a mean age of 58.2 ± 15.1 years. 70% of patients were admitted to the ICU, 44.4% died, 97% required oxygen, and 63.7% required intubation. After adjusted analysis, the factors intubation (p=0.02) and prophylactic anticoagulation (p<0.001) were associated with VTE. The following variables were shown to be important risk factors for VTE: intubation (OR 2.3; 95% CI 1.1-4.8, p=0.020) and excess weight (OR 3.3; 95% CI 0.2-2.2, p=0.02), while prophylactic anticoagulation showed a small protective factor (OR 0.02; 95% CI 0.01-0.04, p<0.001). Conclusions: The results demonstrate how COVID-19, together with several other associated factors, especially intubation, excess weight, and use of anticoagulants, may be related to thromboembolism as risk factors and protective factors. Prophylactic anticoagulation, in particular, was a protective factor.

Indexed as

anticoagulantsCOVID-19excess weightintubationpulmonary thromboembolismvenous thromboembolismvenous thrombosis

Identifiers

PMID40785976
PMCPMC12334124

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.